On this episode of Raise the Line, we have the privilege of hearing from one of the nation's top healthcare leaders, Dr. Joshua Gordon, who is the director of the National Institute of Mental Health. In that role, he oversees an extensive portfolio of basic and clinical research that seeks to transform the understanding and treatment of mental illnesses, paving the way for prevention, recovery and cure. “Our main role is in trying to make sure that good science is conducted in the service of furthering public mental health,” he tells host Shiv Gaglani. One area of NIMH research that gets less attention than breakthrough medicines is how to make it easier for healthcare systems and practices to adopt best practices and proven treatments. This not only helps improve patient outcomes, but Gordon says it is one element in addressing feelings of a lack of effectiveness that contribute to provider burnout. “If we can increase individuals’ efficacy by ensuring that they are trained in evidence-based approaches, and continue to make new treatments available to help those who aren't responding to the old ones, that's one way we can do that.” This is a rare opportunity to hear from a federal agency executive on some of the most pressing and interesting issues in healthcare including the shortage of providers, health equity, social determinants of health, telemedicine and the potential for psychedelics to treat mental health problems.
Mentioned in this episode: https://www.nimh.nih.gov/
If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast
